{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:07:25Z","timestamp":1768810045768,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,7,7]],"date-time":"2011-07-07T00:00:00Z","timestamp":1309996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s12013-011-9221-5","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T09:01:29Z","timestamp":1309942889000},"page":"461-466","source":"Crossref","is-referenced-by-count":13,"title":["Plasma Paraoxonase-1, Oxidized Low-Density Lipoprotein and Lipid Peroxidation Levels in Gout Patients"],"prefix":"10.1007","volume":"61","author":[{"given":"Xing-Liang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Guo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Jun","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,7]]},"reference":[{"key":"9221_CR1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","volume":"143","author":"HK Choi","year":"2005","unstructured":"Choi, H. K., Mount, D. B., & Reginato, A. M. (2005). Pathogenesis of gout. Annals of Internal Medicine, 143, 499\u2013516.","journal-title":"Annals of Internal Medicine"},{"key":"9221_CR2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archinte.168.10.1104","volume":"168","author":"E Krishnan","year":"2008","unstructured":"Krishnan, E., Svendsen, K., Neaton, J. D., Grandits, G., & Kuller, L. H. (2008). Long-term cardiovascular mortality among middle-aged men with gout. Archives of Internal Medicine, 168, 1104\u20131110.","journal-title":"Archives of Internal Medicine"},{"key":"9221_CR3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/ard.54.2.90","volume":"54","author":"S Takahashi","year":"1995","unstructured":"Takahashi, S., Yamamoto, T., Moriwaki, Y., Tsutsumi, Z., & Higashino, K. (1995). Increased concentrations of serum Lp(a) lipoprotein in patients with primary gout. Annals of the Rheumatic Diseases, 54, 90\u201393.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"9221_CR4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/rheumatology\/ken471","volume":"48","author":"A Mak","year":"2009","unstructured":"Mak, A., Ho, R. C. M., Tan, J. Y. S., et al. (2009). Atherogenic serum lipid profile is an independent predictor for gouty flares in patients with gouty arthropathy. Rheumatology, 48, 262\u2013265.","journal-title":"Rheumatology"},{"key":"9221_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10067-004-0978-4","volume":"24","author":"TT Cheng","year":"2005","unstructured":"Cheng, T. T., Lai, H. M., Chang, H. W., & Luo, S. F. (2005). Elevated serum homocysteine levels for gouty patients. Clinical Rheumatology, 24, 103\u2013106.","journal-title":"Clinical Rheumatology"},{"key":"9221_CR6","first-page":"1","volume":"3","author":"E Krishnan","year":"2010","unstructured":"Krishnan, E. (2010). Inflammation, oxidative stress and lipids: The risk triad for atherosclerosis in gout. Rheumatology, 3, 1\u201310.","journal-title":"Rheumatology"},{"key":"9221_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000161050.77646.68","volume":"25","author":"NR Madamanchi","year":"2005","unstructured":"Madamanchi, N. R., Vendrov, A., & Runge, M. S. (2005). Oxidative stress and vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 29\u201338.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"9221_CR8","first-page":"699","volume":"33","author":"M Hahn","year":"1994","unstructured":"Hahn, M., & Subbiah, M. T. (1994). Significant association of lipid peroxidation products with high density lipoproteins. Biochemistry and Molecular Biology International, 33, 699\u2013704.","journal-title":"Biochemistry and Molecular Biology International"},{"key":"9221_CR9","doi-asserted-by":"crossref","first-page":"20963","DOI":"10.1074\/jbc.272.34.20963","volume":"272","author":"D Steinberg","year":"1997","unstructured":"Steinberg, D. (1997). Low density lipoprotein oxidation and its pathobiological significance. The Journal of Biological Chemistry, 272, 20963\u201320966.","journal-title":"The Journal of Biological Chemistry"},{"key":"9221_CR10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ncpendmet0245","volume":"2","author":"M Navab","year":"2006","unstructured":"Navab, M., Anantharamaiah, G. M., Reddy, S. T., Van Lenten, B. J., Ansell, B. J., & Fogelman, A. M. (2006). Mechanisms of disease: Proatherogenic HDL\u2014an evolving field. Nature Clinical Practice Endocrinology & Metabolism, 2, 504\u2013511.","journal-title":"Nature Clinical Practice Endocrinology & Metabolism"},{"key":"9221_CR11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.mol.0000137227.54278.29","volume":"15","author":"M Mackness","year":"2004","unstructured":"Mackness, M., Durrington, P., & Mackness, B. (2004). Paraoxonase-1 activity, concentration and genotype in cardiovascular disease. Current Opinion in Lipidology, 15, 399\u2013404.","journal-title":"Current Opinion in Lipidology"},{"key":"9221_CR12","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/hq0901.094247","volume":"21","author":"B Mackness","year":"2001","unstructured":"Mackness, B., Davies, G. K., Turkie, W., et al. (2001). Paraoxonase status in coronary heart disease: Are activity and concentration more important than genotype? Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 1451\u20131457.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"9221_CR13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","volume":"11","author":"H Esterbauer","year":"1991","unstructured":"Esterbauer, H., Schaur, R. J., & Zollner, H. (1991). Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radical Biology and Medicine, 11, 81\u2013128.","journal-title":"Free Radical Biology and Medicine"},{"key":"9221_CR14","doi-asserted-by":"crossref","first-page":"C3424","DOI":"10.1152\/ajpcell.1996.271.5.C1424","volume":"271","author":"JS Beckman","year":"1996","unstructured":"Beckman, J. S., & Koppenol, W. H. (1996). Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. American Journal of Physiology, 271, C3424\u20133437.","journal-title":"American Journal of Physiology"},{"key":"9221_CR15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"1997","unstructured":"Wallace, S. L., Robinson, H., Masi, A. T., Decker, J. L., McCarty, D. J., & Yu, T. F. (1997). Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis and Rheumatism, 20, 895\u2013900.","journal-title":"Arthritis and Rheumatism"},{"key":"9221_CR16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/clinchem\/48.2.261","volume":"48","author":"N Ferre","year":"2008","unstructured":"Ferre, N., Camps, J., Prats, E., et al. (2008). Serum paraoxonase activity: A new additional test for the improved evaluation of chronic liver damage. Clinical Chemistry, 48, 261\u2013268.","journal-title":"Clinical Chemistry"},{"key":"9221_CR17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0891-5849(98)00272-X","volume":"26","author":"M Aviram","year":"1999","unstructured":"Aviram, M., Rosenblat, M., Billecke, S., et al. (1999). Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radical Biology and Medicine, 26, 892\u2013904.","journal-title":"Free Radical Biology and Medicine"},{"key":"9221_CR18","first-page":"307","volume":"9","author":"K Nakamura","year":"1987","unstructured":"Nakamura, K., Endo, H., & Kashiwazaki, S. (1987). Serum oxidation activities and rheumatoid arthritis. International Journal of Tissue Reactions, 9, 307\u2013316.","journal-title":"International Journal of Tissue Reactions"},{"key":"9221_CR19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.ATV.17.7.1233","volume":"17","author":"B Mackness","year":"1997","unstructured":"Mackness, B., Hunt, R., Durrington, P. N., & Mackness, M. I. (1997). Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 1233\u20131238.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"9221_CR20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0021-9150(98)00084-7","volume":"139","author":"KR Feingold","year":"1998","unstructured":"Feingold, K. R., Memon, R. A., Moser, A. H., & Grunfeld, C. (1998). Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis, 139, 307\u2013315.","journal-title":"Atherosclerosis"},{"key":"9221_CR21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","volume":"286","author":"MI Mackness","year":"1991","unstructured":"Mackness, M. I., Arrol, S., & Durrington, P. N. (1991). Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Letters, 286, 152\u2013154.","journal-title":"FEBS Letters"},{"key":"9221_CR22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cyto.2005.11.010","volume":"33","author":"T Inokuchi","year":"2006","unstructured":"Inokuchi, T., Moriwaki, Y., Tsutsui, H., et al. (2006). Plasma interleukin (IL)-18 (interferon-gamma-inducing factor) and other inflammatory cytokines in patients with gouty arthritis and monosodium urate monohydrate crystal-induced secretion of IL-18. Cytokine, 33, 21\u201327.","journal-title":"Cytokine"},{"key":"9221_CR23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13506120209114817","volume":"9","author":"Y Kumon","year":"2002","unstructured":"Kumon, Y., Nakauchi, Y., Suehiro, T., et al. (2002). Proinflammatory cytokines but not acute phase serum amyloid A or C-reactive protein, downregulate paraoxonase 1 (PON1) expression by HepG2 cells. Amyloid, 9, 160\u2013164.","journal-title":"Amyloid"},{"key":"9221_CR24","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.freeradbiomed.2004.08.012","volume":"37","author":"RW James","year":"2004","unstructured":"James, R. W., & Deakin, S. P. (2004). The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity. Free Radical Biology and Medicine, 37, 1986\u20131994.","journal-title":"Free Radical Biology and Medicine"},{"key":"9221_CR25","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1074\/jbc.M107440200","volume":"277","author":"S Deakin","year":"2002","unstructured":"Deakin, S., Leviev, I., Gomaraschi, M., Calabresi, L., Franceschini, G., & James, R. W. (2002). Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. The Journal of Biological Chemistry, 277, 4301\u20134308.","journal-title":"The Journal of Biological Chemistry"},{"key":"9221_CR26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1056-8727(01)00191-X","volume":"16","author":"S Rashid","year":"2002","unstructured":"Rashid, S., Uffelman, K. D., & Lewis, G. F. (2002). The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states. Journal of Diabetes Complications, 16, 24\u201328.","journal-title":"Journal of Diabetes Complications"},{"key":"9221_CR27","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1001\/jama.266.21.3004","volume":"266","author":"R Roubenoff","year":"1991","unstructured":"Roubenoff, R., Klag, M. J., Mead, L. A., Liang, K. Y., Seidler, A. J., & Hochberg, M. C. (1991). Incidence and risk factors for gout in white men. The Journal of the American Medical Association, 266, 3004\u20133007.","journal-title":"The Journal of the American Medical Association"},{"key":"9221_CR28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1194\/jlr.M200407-JLR200","volume":"44","author":"RA Patterson","year":"2003","unstructured":"Patterson, R. A., Horsley, E. T., & Leake, D. S. (2003). Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: Important role of uric acid. Journal of Lipid Research, 44, 512\u2013521.","journal-title":"Journal of Lipid Research"},{"key":"9221_CR29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0014-5793(99)00231-8","volume":"446","author":"PM Abuja","year":"1999","unstructured":"Abuja, P. M. (1999). Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein. FEBS Letters, 446, 305\u2013308.","journal-title":"FEBS Letters"},{"key":"9221_CR30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-0773.2003.pto930606.x","volume":"93","author":"S Muraoka","year":"2003","unstructured":"Muraoka, S., & Miura, T. (2003). Inhibition by uric acid of free radicals that damage biological molecules. Pharmacology and Toxicology, 93, 284\u2013289.","journal-title":"Pharmacology and Toxicology"},{"key":"9221_CR31","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0021-9258(19)77933-2","volume":"263","author":"KR Maples","year":"1988","unstructured":"Maples, K. R., & Mason, R. P. (1988). Free radical metabolite of uric acid. The Journal of Biological Chemistry, 263, 1709\u20131712.","journal-title":"The Journal of Biological Chemistry"},{"key":"9221_CR32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/abbi.1999.1491","volume":"372","author":"CX Santos","year":"1999","unstructured":"Santos, C. X., Anjos, E. I., & Augusto, O. (1999). Uric acid oxidation by peroxynitrite: Multiple reactions, free radical formation, and amplification of lipid oxidation. Archives of Biochemistry and Biophysics, 372, 285\u2013294.","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"9221_CR33","doi-asserted-by":"crossref","first-page":"C584","DOI":"10.1152\/ajpcell.00600.2006","volume":"293","author":"YY Sautin","year":"2007","unstructured":"Sautin, Y. Y., Nakagawa, T., Zharikov, S., & Johnson, R. J. (2007). Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase mediated oxidative\/nitrosative stress. American Journal of Physiology, 293, C584\u2013C596.","journal-title":"American Journal of Physiology"},{"key":"9221_CR34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00726-006-0425-8","volume":"32","author":"S Bartesaghi","year":"2007","unstructured":"Bartesaghi, S., Ferrer-Sueta, G., Peluffo, G., et al. (2007). Protein tyrosine nitration in hydrophilic and hydrophobic environments. Amino Acids, 32, 501\u2013515.","journal-title":"Amino Acids"},{"key":"9221_CR35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/0264-6021:3400143","volume":"340","author":"M Bagnati","year":"1999","unstructured":"Bagnati, M., Perugini, C., Cau, C., Bordone, R., Albano, E., & Bellomo, G. (1999). When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: A study using uric acid. Biochemical Journal, 340, 143\u2013152.","journal-title":"Biochemical Journal"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-011-9221-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12013-011-9221-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-011-9221-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T17:31:13Z","timestamp":1638034273000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12013-011-9221-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,7]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["9221"],"URL":"https:\/\/doi.org\/10.1007\/s12013-011-9221-5","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,7]]}}}